Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Webster

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Medicinal chemistry approaches to avoid aldehyde oxidase metabolismDavid C Pryde, Thien-Duc Tran, Peter Jones, et al.
Chemmedchem|October 16, 2008
Optimization of 5-aryloxyimidazole non-nucleoside reverse transcriptase inhibitorsLyn H Jones, Gill Allan, Romuald Corbau, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2007
The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPDAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2009
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidateCharles E Mowbray, Catherine Burt, Romuald Corbau, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
The discovery of adamantyl-derived, inhaled, long acting beta(2)-adrenoreceptor agonistsAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
The discovery of long acting beta2-adrenoreceptor agonistsAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activityPatrick Dorr, Mike Westby, Susan Dobbs, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 1Thien Duc Tran, Florian Wakenhut, Chris Pickford, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2Florian Wakenhut, Thien Duc Tran, Chris Pickford, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Medicinal chemistry approaches to avoid aldehyde oxidase metabolismDavid C Pryde, Thien-Duc Tran, Peter Jones, et al.
Chemmedchem|October 16, 2008
Optimization of 5-aryloxyimidazole non-nucleoside reverse transcriptase inhibitorsLyn H Jones, Gill Allan, Romuald Corbau, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2007
The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPDAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2009
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidateCharles E Mowbray, Catherine Burt, Romuald Corbau, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
The discovery of adamantyl-derived, inhaled, long acting beta(2)-adrenoreceptor agonistsAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
The discovery of long acting beta2-adrenoreceptor agonistsAlan D Brown, Mark E Bunnage, Paul A Glossop, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activityPatrick Dorr, Mike Westby, Susan Dobbs, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 1Thien Duc Tran, Florian Wakenhut, Chris Pickford, et al.
Chemmedchem|April 15, 2014
The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile-Part 2Florian Wakenhut, Thien Duc Tran, Chris Pickford, et al.
Pageof 3